S&P 500
(0.13%) 5 106.39 points
Dow Jones
(0.21%) 38 321 points
Nasdaq
(0.17%) 15 954 points
Oil
(-1.41%) $82.67
Gas
(5.67%) $2.03
Gold
(0.12%) $2 350.10
Silver
(-0.17%) $27.49
Platinum
(3.88%) $957.85
USD/EUR
(-0.21%) $0.933
USD/NOK
(-0.34%) $10.99
USD/GBP
(-0.51%) $0.796
USD/RUB
(1.69%) $93.43

Realtime updates for Lumos Pharma Inc [LUMO]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Upcoming Earnings Alert

2 days till quarter result
(bmo 2024-05-01)

Expected move: +/- 10.54%

Last Updated29 Apr 2024 @ 14:37

1.24% $ 2.86

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 14:37):

Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare endocrine disorders...

Stats
Today's Volume 11 762.00
Average Volume 20 009.00
Market Cap 23.19M
EPS $0 ( 2024-03-07 )
Next earnings date ( $-1.210 ) 2024-05-01
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.680
ATR14 $0.0290 (1.01%)
Insider Trading
Date Person Action Amount type
2024-01-04 Pitukcheewanont Pisit Duke Sell 0 Common Stock
2023-06-01 Pitukcheewanont Pisit Duke Sell 29 750 Stock Option (Right to Buy)
2024-02-01 Pitukcheewanont Pisit Duke Sell 3 333 Stock Option (Right to Buy)
2024-07-01 Pitukcheewanont Pisit Duke Sell 25 500 Stock Option (Right to Buy)
2023-08-01 Mckew John C. Sell 1 593 Common Stock
INSIDER POWER
24.11
Last 99 transactions
Buy: 596 623 | Sell: 145 033

Lumos Pharma Inc Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Lumos Pharma Inc Financials

Annual 2023
Revenue: $2.05M
Gross Profit: $2.01M (97.85 %)
EPS: $-4.18
FY 2023
Revenue: $2.05M
Gross Profit: $2.01M (97.85 %)
EPS: $-4.18
FY 2022
Revenue: $1.52M
Gross Profit: $1.47M (96.78 %)
EPS: $-3.71
FY 2021
Revenue: $230.00
Gross Profit: $0.00 (0.00 %)
EPS: $-0.00365

Financial Reports:

No articles found.

Lumos Pharma Inc

Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare endocrine disorders. The company is headquartered in Austin, Texas.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators